New fat targeting device launches

10 Jan 2022

British medical device company Gelida Medica has introduced the Waves 21 device to its portfolio.

According to the company, the device targets subcutaneous and visceral fat by using a combination of techniques, including metameric stimulation. A sinusoidal waveform is emitted to stimulate the metameres through the nervous system, helping to improve and reduce the specific problem whilst targeting visceral fat, explains the company. 

The device can be used on all areas of the body, except breast tissue and treatment benefits include removal of stomach fat and cellulite and skin tightening and firming.


Log-in to post a comment